1. Home
  2. ARWR vs DQ Comparison

ARWR vs DQ Comparison

Compare ARWR & DQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • DQ
  • Stock Information
  • Founded
  • ARWR 2003
  • DQ 2006
  • Country
  • ARWR United States
  • DQ China
  • Employees
  • ARWR N/A
  • DQ N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • DQ Semiconductors
  • Sector
  • ARWR Health Care
  • DQ Technology
  • Exchange
  • ARWR Nasdaq
  • DQ Nasdaq
  • Market Cap
  • ARWR 1.8B
  • DQ 1.4B
  • IPO Year
  • ARWR 1993
  • DQ 2010
  • Fundamental
  • Price
  • ARWR $13.07
  • DQ $13.02
  • Analyst Decision
  • ARWR Buy
  • DQ Hold
  • Analyst Count
  • ARWR 11
  • DQ 6
  • Target Price
  • ARWR $41.44
  • DQ $20.31
  • AVG Volume (30 Days)
  • ARWR 1.7M
  • DQ 880.8K
  • Earning Date
  • ARWR 05-12-2025
  • DQ 04-29-2025
  • Dividend Yield
  • ARWR N/A
  • DQ N/A
  • EPS Growth
  • ARWR N/A
  • DQ N/A
  • EPS
  • ARWR N/A
  • DQ N/A
  • Revenue
  • ARWR $2,500,000.00
  • DQ $737,683,000.00
  • Revenue This Year
  • ARWR $4,380.43
  • DQ N/A
  • Revenue Next Year
  • ARWR $64.24
  • DQ $66.29
  • P/E Ratio
  • ARWR N/A
  • DQ N/A
  • Revenue Growth
  • ARWR N/A
  • DQ N/A
  • 52 Week Low
  • ARWR $9.57
  • DQ $12.41
  • 52 Week High
  • ARWR $30.41
  • DQ $30.85
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 53.31
  • DQ 37.84
  • Support Level
  • ARWR $12.44
  • DQ $12.72
  • Resistance Level
  • ARWR $14.97
  • DQ $13.45
  • Average True Range (ATR)
  • ARWR 0.71
  • DQ 0.69
  • MACD
  • ARWR 0.16
  • DQ 0.13
  • Stochastic Oscillator
  • ARWR 61.36
  • DQ 22.47

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

About DQ DAQO New Energy Corp.

Daqo New Energy Corp is a polysilicon manufacturer based in China. The company manufactures and sells high-purity polysilicon to manufacturers who use it to make ingots, cells, and modules for solar power solutions. The polysilicon is packaged to meet crucible stacking, pulling, and solidification needs. All of the company's revenues come from the People's Republic of China.

Share on Social Networks: